Please sign in to follow a disease.
Stephan Grupp Md Phd
Clinical trials sponsored by Stephan Grupp Md Phd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New CAR T-Cell therapy shows promise for kids with tough leukemia Results expected Sep 2027 (estimated)
-
Engineered immune cells take on childhood cancers in first human trial
Disease control By invitation onlyThis early-stage trial is testing a new treatment called GPC2 CAR T cells for children with neuroblastoma or retinoblastoma that has come back or not responded to standard treatments. The therapy uses a patient's own immune cells, which are modified in a lab to better recognize a…
Phase 1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Engineered immune cells take aim at childhood cancer
Disease control OngoingThis early-stage trial is testing a new type of cell therapy for children with neuroblastoma that has returned or is hard to treat. The therapy uses the patient's own immune cells, which are modified in the lab to recognize and attack a protein called PHOX2B found on neuroblastom…
Phase 1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC